GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Deferred Tax

CHO Pharma (ROCO:6586) Deferred Tax : NT$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CHO Pharma Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

CHO Pharma's change in deferred tax for the six months ended in Dec. 2024 was NT$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.00 Mil.

CHO Pharma Deferred Tax Historical Data

The historical data trend for CHO Pharma's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHO Pharma Deferred Tax Chart

CHO Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CHO Pharma Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CHO Pharma Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHO Pharma Deferred Tax Related Terms

Thank you for viewing the detailed overview of CHO Pharma's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

CHO Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Deferred Tax
Comparable Companies
ROCO:6976 ROCO:6696 ROCO:4174 TPE:6541 TPE:4142 ROCO:7759 ROCO:6617 TPE:6949 ROCO:4157 ROCO:6875 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 18F, Building F, Nangang, Taipei, TWN, 11503
Website
http://www.chopharma.com
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.

CHO Pharma Headlines

No Headlines